Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	275	388	465	157	29	35
Market Cap Growth	-59.81%	-16.54%	195.83%	434.24%	-16.81%	-42.59%
Enterprise Value	241	373	468	159	27	31
Last Close Price	0.26	0.36	0.43	0.15	0.03	0.03

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	5.81	8.64	-	7.81	8.26	3.97
PS Ratio	1.95	2.61	5.53	2.77	0.86	1.10
PB Ratio	2.62	3.92	8.68	2.73	1.01	1.40
P/TBV Ratio	2.62	3.92	8.73	2.74	1.03	1.43
P/FCF Ratio	15.68	16.99	79.70	-	-	5.88
P/OCF Ratio	14.43	16.33	62.33	-	8.81	5.43

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.71	2.50	5.56	2.81	0.80	0.96
EV/EBITDA Ratio	6.36	7.24	20.43	13.09	5.25	4.94
EV/EBIT Ratio	6.75	7.46	22.05	14.75	6.92	6.11
EV/FCF Ratio	13.77	16.33	80.19	-	-	5.15

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.05	0.06	0.20	0.20	0.13	0.11
Debt / EBITDA Ratio	0.15	0.11	0.46	0.95	0.73	0.43
Debt / FCF Ratio	0.32	0.26	1.87	-	-	0.46
Net Debt / Equity Ratio	-0.32	-0.24	-0.01	0.08	-0.14	-0.23
Net Debt / EBITDA Ratio	-0.89	-0.47	-0.02	0.38	-0.75	-0.92
Net Debt / FCF Ratio	-1.90	-1.05	-0.07	-1.14	1.65	-0.96
Asset Turnover	1.12	1.27	0.93	0.91	0.90	1.05
Inventory Turnover	3.66	3.94	3.01	2.69	2.16	2.97
Quick Ratio	2.94	5.15	3.42	2.04	1.40	1.73
Current Ratio	3.76	6.45	4.88	3.07	2.75	2.82
Return on Equity (ROE)	74.31%	58.89%	-7.77%	46.47%	13.15%	43.01%
Return on Assets (ROA)	17.82%	26.61%	14.72%	10.83%	6.52%	10.33%
Return on Invested Capital (ROIC)	42.58%	61.65%	36.77%	24.74%	15.95%	29.14%
Return on Capital Employed (ROCE)	32.80%	41.30%	25.10%	15.30%	12.00%	17.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	20.62%	11.57%	-0.93%	12.80%	12.11%	25.18%
FCF Yield	6.38%	5.88%	1.26%	-2.57%	-8.15%	17.00%
Buyback Yield / Dilution	-7.97%	-6.56%	-4.40%	-1.02%	-0.23%	-7.17%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error